CDC Guidance on Shortage of Erythromycin (0.5%) Ophthalmic Ointment - September 2009

The AMCNO has learned that there is an impending shortage of erythromycin ointment and that the CDC has issued an alert on this issue. The statement from the Center for Disease Control (CDC) was drafted by the CDC with input from the Food and Drug Administration (FDA), the American Academy of Pediatrics, the American Academy of Family Practice, the American College of Obstetrics/Gynecology and the American Academy of Ophthalmology.

CDC continues to work with the U.S. Food and Drug Administration (FDA) and other experts to provide updates regarding the shortage of Erythromycin Ophthalmic Ointment (0.5%). This page provides guidance on securing supplies and recommendations for preventing increases in the occurrence of ophthalmia neonatorum during the shortage. To view the CDC statement regarding this shortage go to: http://www.cdc.gov/std/treatment/2006/erythromycinOintmentShortage.htm